@article{9687ab67fe8f42efb9c031dca08e5ef3,
title = "What Is the Role of HSCT in Philadelphia-Chromosome-Positive and Philadelphia-Chromosome-Like ALL in the Tyrosine Kinase Inhibitor Era?",
keywords = "haematopoietic stem cell transplantation, tyrosine kinase inhibitors, Philadelphia chromosome, acute lymphoblastic leukaemia, BCR-ABL-like ALL, graft-vs, -host disease, -leukaemia effect, ACUTE LYMPHOBLASTIC-LEUKEMIA, STEM-CELL TRANSPLANTATION, MINIMAL RESIDUAL DISEASE, BONE-MARROW-TRANSPLANTATION, VERSUS-HOST-DISEASE, HIGH-RISK, POSTTRANSPLANTATION CYCLOPHOSPHAMIDE, HEMATOLOGIC MALIGNANCIES, PEDIATRIC-PATIENTS, ADULT PATIENTS, 3123 Gynaecology and paediatrics",
author = "Kim Vettenranta and Veronika Dobsinska and Gabriella Kertesz and Peter Svec and Jochen Buechner and Schultz, {Kirk R.}",
year = "2022",
month = feb,
day = "2",
doi = "10.3389/fped.2021.807002",
language = "English",
volume = "9",
journal = "Frontiers in pediatrics",
issn = "2296-2360",
publisher = "Frontiers Media SA",
}